Citigroup’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-3,969
| Closed | -$92K | – | 5733 |
|
|
2020
Q4 | $92K | Buy |
3,969
+1,270
| +47% | +$29.4K | ﹤0.01% | 3734 |
|
|
2020
Q3 | $27K | Sell |
2,699
-1,314
| -33% | -$13.1K | ﹤0.01% | 3797 |
|
|
2020
Q2 | $60K | Sell |
4,013
-2,656
| -40% | -$39.7K | ﹤0.01% | 3705 |
|
|
2020
Q1 | $81K | Buy |
6,669
+2,546
| +62% | +$30.9K | ﹤0.01% | 3446 |
|
|
2019
Q4 | $65K | Buy |
4,123
+3,736
| +965% | +$58.9K | ﹤0.01% | 3805 |
|
|
2019
Q3 | $5K | Buy |
+387
| New | +$5K | ﹤0.01% | 4816 |
|